Healthcare

Healthcare

Active

axellis
Radiation oncology solutions
United Kingdom

EffRx Pharmaceuticals
Commercial stage osteoporosis drug
Switzerland

Memo Therapeutics
Human antibody repertoire platform

Switzerland

multimmune
Diagnostic platforms and focused therapies for cancer patients
Germany

M.O.R.E Medical Solutions
Orthopaedic and trauma surgery solutions
Germany

NeuroProof
Drug discovery and development services
Germany

Presidio Pharmaceuticals
Hepatitis C drug
USA




Exited

ACT Biotech
Targeted, orally available cancer drugs
USA
Exit 2014

AnalytiCon discovery
Natural product small molecules and analogues libraries
Germany
Exit 2013

ArraVasc
Peripheral balloon catheters
Ireland
Exit 2018

astex Pharmaceuticals
Drugs against cancer
USA
Exit 2013

Atto-Tec
Fluorescent dyes

Germany
Exit 2009

Biobase
Molecular biology databases and tools

Germany
Exit 2012

Biomax Informatics
Bioinformatics software solutions
Germany
Exit 2020

cerbomed
Non-invasive vagus-nerve stimulation device against epilesy
Germany
Exit 2018

chiracon
Chiral intermediates
Germany
Exit 2008

corassist cardiovascular
Medical devices for treatment of heart failure
Israel
Exit 2015

Curadis
Drugs against hormone-dependent diseases such as breast cancer
Germany
Exit 2020

DeveloGen
Metabolic disorders
Germany
Exit 2009

Envoy Medical
Totally implantable hearing aid
USA
Exit 2007

getemed
Vital signs monitors
Germany
Exit 2007

Hybrigenics Pharma
Drugs against cancer

and screening services
France
Exit 2009 (IPO)

IDM Pharma
Drugs against cancer
USA
Exit 2007 (“cold” IPO)

Isarna Therapeutics
Selective TGF-β oligonucleotide inhibitors
Germany
Exit 2021

Lophius Biosciences
T cell-based research tools and diagnostics
Germany
Exit 2020


mtm Laboratories
Cancer diagnostics
Germany
Exit 2018

myoscience
Pain treatment devices
USA
Exit 2019

Neurotech Pharmaceuticals
Ophthalmic diseases
USA
Exit 2016

Noxxon Pharma
Drugs against inflammatory and hermatological diseases
Germany
Exit 2007

Paratek Pharmaceuticals
Drugs against infectious diseases
USA
Exit 2014 (IPO)

Philogen
Drugs against angiogenesis-related disorders
Italy
Exit 2013

physioTEC
Orthopaedics for children
Germany
Exit 2017

Pieris Pharmaceuticals
Therapeutic proteins
USA
Exit 2014 (IPO)

sepiatec
Chromatographic devices (HPLC)
Germany
Exit 2012